BackgroundCheck.run
Search For

Ping Fang ChenCarbondale, IL

Ping Chen Phones & Addresses

Carbondale, IL   

Columbus, OH   

San Diego, CA   

Elmhurst, IL   

47 N Chesterfield Rd, Columbus, OH 43209   

Mentions for Ping Fang Chen

Career records & work history

Medicine Doctors

Ping Chen

Specialties:
Physical Medicine & Rehabilitation
Work:
Southeastern Integrated MedicalSoutheast Integrated Medical Rehabilitation Medicine
1315 NW 21 Ave STE 2, Chiefland, FL 32626
352-4931655 (phone) 352-4908641 (fax)
Site
Languages:
English
Description:
Ms. Chen works in Chiefland, FL and specializes in Physical Medicine & Rehabilitation. Ms. Chen is affiliated with UF Health Shands Rehabilitation Hospital.

License Records

Ping Chen

Licenses:
License #: 4704224720 - Expired
Category: Nursing
Issued Date: May 11, 2000
Expiration Date: Mar 31, 2003
Type: RN

Publications & IP owners

Us Patents

Flexible Printed Circuit Board Crimp Terminal And Crimping Structure For Core Therewith

US Patent:
6350145, Feb 26, 2002
Filed:
Jan 5, 2000
Appl. No.:
09/477670
Inventors:
Ping Chen - Mundelein IL
Takashi Iida - Anjo, JP
Assignee:
Japan Solderless Terminal Mfg. Co., Ltd. - Osaka-fu
International Classification:
H01R 424
US Classification:
439422, 439877
Abstract:
An FPC crimp terminal comprising a bottom plate being formed from a flat plate and a fixing part rising from an edge of the bottom plate, said FPC crimp terminal being formed in such a way that when a core or a lead wire is brought into direct contact with a conductor of an FPC, the fixing part is made to pierce the FPC from its back or front and the top end of the fixing part coming out of the FPC is bent towards the bottom plate, the core or the lead wire and the FPC will be pinched between the top end of the fixing part and the bottom plate. As the fixing part is used to effect the piercing process and the connecting process at the same time, the FPC crimp terminal can be compactified and the work efficiency can be enhanced through reduction in the number of processes.

Female Terminal For A Connector And A Housing Therefor

US Patent:
6379199, Apr 30, 2002
Filed:
Sep 9, 1999
Appl. No.:
09/392582
Inventors:
Ping Chen - Mundelein IL
Assignee:
Japan Solderless Terminal Mfg. Co., Ltd. - Osaka
International Classification:
H01R 1122
US Classification:
439852, 439451
Abstract:
A female terminal for a connector wherein a leaf spring is provided inside the terminal proper. The front half of the terminal proper is provided with a bottom wall, side walls rising from both ends, in the direction of width, of the bottom wall, an outer upper wall and an inner upper wall extending from the upper edges of side walls to the upper edges of the opposing side walls. A leaf spring is formed by separating said rear inner upper wall from said side walls, with the rear end of said rear inner upper wall being left intact. A bead with a curved section is formed on the leaf spring to increase the flexural rigidity. The female terminal can be compactified, and a sufficient contacting force can be provided reliably. The contacting part of the leaf spring can be shifted forward. The developed shape can be made smaller.

Catalytic Domain Of The Human Effector Cell Cycle Checkpoint Protein Kinase Materials And Methods For Identification Of Inhibitors Thereof

US Patent:
6670167, Dec 30, 2003
Filed:
Dec 14, 1999
Appl. No.:
09/460421
Inventors:
Ping Chen - San Diego CA
Mark Anderson - San Diego CA
Ya-Li Deng - San Diego CA
Smita Gaur - San Diego CA
Chen Chen Kan - Arcadia CA
Chun Luo - San Diego CA
Karen Lundgren - San Diego CA
Stephen Margosiak - Escondido CA
Binh Nguyen - San Diego CA
Patrick OConnor - San Diego CA
James Register - San Diego CA
Anna Tempczyk Russell - San Diego CA
Jay Sarup - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07H 2104
US Classification:
43525233, 4352351, 435348, 43525411, 4352523, 435419, 435325, 4353201, 536 232, 536 235
Abstract:
The present invention relates to the identification, isolation and purification of the catalytic domain of the human effector checkpoint protein kinase (hChk1). A 1. 7 crystal structure of the hChk1 kinase domain in the active conformation is reported herein. The kinase domain of hChk1 and its associated crystal structure is described for use in the discovery, identification and characterization of inhibitors of hChk1. This structure provides a three-dimensional description of the binding site of the hChk1 for structure-based design of small molecule inhibitors thereof as therapeutic agents. Inhibitors of hChk1 find utility in the treatment of hyperproliferative disorders such as HIV and cancer.

Catalytic Domain Of The Human Effector Cell Cycle Checkpoint Protein Kinase Chk1 Materials And Methods For Identification Of Inhibitors Thereof

US Patent:
2003023, Dec 25, 2003
Filed:
Jan 28, 2003
Appl. No.:
10/353274
Inventors:
Ping Chen - San Diego CA, US
Mark Anderson - San Diego CA, US
Ya-Li Deng - San Diego CA, US
Smita Gaur - San Diego CA, US
Chen Kan - Arcadia CA, US
Chun Luo - San Diego CA, US
Karen Lundgren - San Diego CA, US
Stephen Margosiak - Escondido CA, US
Binh Nguyen - San Diego CA, US
Patrick O'Connor - San Diego CA, US
James Reqister - San Diego CA, US
Anna Russell - San Diego CA, US
Jay Sarup - San Diego CA, US
International Classification:
C12P021/02
C07H021/04
C12N009/12
C12N005/06
US Classification:
435/194000, 435/069100, 435/320100, 435/325000, 536/023200
Abstract:
The present invention relates to the identification, isolation and purification of the catalytic domain of the human effector checkpoint protein kinase (hChk1). A 1.7 crystal structure of the hChk1 kinase domain in the active conformation is reported herein. The kinase domain of hChk1 and its associated crystal structure is described for use in the discovery, identification and characterization of inhibitors of hChk1. This structure provides a three-dimensional description of the binding site of the hChk1 for structure-based design of small molecule inhibitors thereof as therapeutic agents. Inhibitors of hChk1 find utility in the treatment of hyperproliferative disorders such as HIV and cancer.

Female Terminal For A Connector And A Housing Therefor

US Patent:
6174208, Jan 16, 2001
Filed:
Jul 7, 1999
Appl. No.:
9/348393
Inventors:
Ping Chen - Mundelein IL
Assignee:
Japan Solderless Terminal Mfg. Co., Ltd. - Osaka
International Classification:
H01R 1122
US Classification:
439852
Abstract:
A female terminal for a connector comprising a terminal body that is fixed by a retainer of a housing, a leaf spring that extends forward in the terminal body, and a stabilizer that is fixed by a lance of the housing. At the root end of the leaf spring, a round part that bends lengthwise into an approximately circular arc is formed. A bead having a curved section to increase flexural rigidity of the leaf spring is formed ahead of the round part on the top end side. A stabilizer having a face directed in the width direction is erected in the height direction from the top end of the terminal body.

Cdk2/4/6 Inhibitors

US Patent:
2022032, Oct 13, 2022
Filed:
Jun 15, 2022
Appl. No.:
17/841138
Inventors:
- New York NY, US
Ping Chen - San Diego CA, US
Kevin Daniel Freeman-Cook - Carlsbad CA, US
Robert Louis Hoffman - San Diego CA, US
Mehran Jalaie - San Diego CA, US
Asako Nagata - San Diego CA, US
Sajiv Krishnan Nair - Vista CA, US
Sacha Ninkovic - La Jolla CA, US
Martha Alicia Ornelas - San Diego CA, US
Cynthia Louise Palmer - La Mesa CA, US
Eugene Yuanjin Rui - San Diego CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 487/04
C07D 471/04
C07D 401/14
Abstract:
This invention relates to compounds of general Formula (I)

Tricyclic Pyridones And Pyrimidones

US Patent:
2023010, Apr 6, 2023
Filed:
Dec 20, 2021
Appl. No.:
17/556498
Inventors:
- San Diego CA, US
Jean-Michel VERNIER - San Diego CA, US
Marcos GONZALEZ-LOPEZ - San Diego CA, US
Benjamin JONES - San Diego CA, US
Nicholas A. ISLEY - San Diego CA, US
Ping CHEN - San Diego CA, US
International Classification:
C07D 513/06
C07D 519/00
C07D 513/20
A61P 35/00
Abstract:
Compounds with KRAS G12C inhibitory active are disclosed and methods of using the same to treat a cancer comprising a K-Ras G12C mutation.

Cdk2/4/6 Inhibitors

US Patent:
2020039, Dec 17, 2020
Filed:
Aug 27, 2020
Appl. No.:
17/005233
Inventors:
- New York NY, US
Ping Chen - San Diego CA, US
Kevin Daniel Freeman-Cook - Carlsbad CA, US
Robert Louis Hoffman - San Diego CA, US
Mehran Jalaie - San Diego CA, US
Asako Nagata - San Diego CA, US
Sajiv Krishnan Nair - Vista CA, US
Sacha Ninkovic - La Jolla CA, US
Martha Alicia Ornelas - San Diego CA, US
Cynthia Louise Palmer - La Mesa CA, US
Eugene Yuanjin Rui - San Diego CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 487/04
C07D 471/04
C07D 401/14
Abstract:
This invention relates to compounds of general Formula (1)

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.